Literature DB >> 19957114

Influence of formulation factors on tablet formulations with liquid permeation enhancer using factorial design.

Naveen K Bejugam1, Helen J Parish, Gita N Shankar.   

Abstract

For a drug with low bioavailability, a matrix tablet with liquid permeation enhancer (Labrasol) was formulated. Factorial design was used to evaluate the effect of three formulation factors: drug percentage, polymer type (Methocel K100M or Eudragit L 100-55), and tablet binder percentage (Plasdone S-630) on tablet characteristics. Tablets were prepared by direct compression and characterized. Compressibility index values ranged between 15.90% and 29.87% and tablet hardness values from 7.8 to 29.78 Kp. Eudragit-containing formulations had better compressibility index values with higher tablet hardness. Time for 75% of drug release (T75) was calculated, and formulations containing Eudragit L 100-55 had faster release rates than tablet formulations with Methocel K100M. Formulations with Methocel K100M fit well in the Higuchi model as indicated by their R2 values (>0.98). Among all the formulation factors studied, polymer type displayed the highest and statistically significant effect on compressibility index, tablet hardness, and dissolution rate. Statistical design helped in better understanding the effect of formulation factors on tablet characteristics important for designing formulations with desired characteristics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19957114      PMCID: PMC2799611          DOI: 10.1208/s12249-009-9345-8

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  30 in total

Review 1.  Modeling and comparison of dissolution profiles.

Authors:  P Costa; J M Sousa Lobo
Journal:  Eur J Pharm Sci       Date:  2001-05       Impact factor: 4.384

2.  Fluid bed granulation of a poorly water soluble, low density, micronized drug: comparison with high shear granulation.

Authors:  Julia Z H Gao; A Jain; R Motheram; D B Gray; M A Hussain
Journal:  Int J Pharm       Date:  2002-04-26       Impact factor: 5.875

3.  Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients.

Authors:  S Nazzal; M Nutan; A Palamakula; R Shah; A A Zaghloul; M A Khan
Journal:  Int J Pharm       Date:  2002-06-20       Impact factor: 5.875

4.  Release of ketoprofen enantiomers from HPMC K100M matrices--diffusion studies.

Authors:  M A Solinís; Y de la Cruz; R M Hernández; A R Gascón; B Calvo; J L Pedraz
Journal:  Int J Pharm       Date:  2002-06-04       Impact factor: 5.875

5.  Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets.

Authors:  S Takka; S Rajbhandari; A Sakr
Journal:  Eur J Pharm Biopharm       Date:  2001-07       Impact factor: 5.571

Review 6.  Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.

Authors:  C W Pouton
Journal:  Eur J Pharm Sci       Date:  2000-10       Impact factor: 4.384

7.  Evaluation of the deformation behavior of binary systems of methacrylic acid copolymers and hydroxypropyl methylcellulose using a compaction simulator.

Authors:  Aditya S Tatavarti; Francis X Muller; Stephen W Hoag
Journal:  Int J Pharm       Date:  2007-07-07       Impact factor: 5.875

8.  Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.

Authors:  Kavita H Khanvilkar; Ye Huang; Angela D Moore
Journal:  Drug Dev Ind Pharm       Date:  2002-05       Impact factor: 3.225

9.  Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation.

Authors:  Nilüfer Yüksel; Aysegül Karataş; Yalçin Ozkan; Ayhan Savaşer; Sibel A Ozkan; Tamer Baykara
Journal:  Eur J Pharm Biopharm       Date:  2003-11       Impact factor: 5.571

10.  Evaluation of oral formulations of gentamicin containing labrasol in beagle dogs.

Authors:  Y V Rama Prasad; Sudarat Eaimtrakarn; Makoto Ishida; Yoichi Kusawake; Riichi Tawa; Yukako Yoshikawa; Nobuhito Shibata; Kanji Takada
Journal:  Int J Pharm       Date:  2003-12-11       Impact factor: 5.875

View more
  2 in total

1.  A Controlled Release Theophylline Delivery System Based on a Bilayer Floating System.

Authors:  John Afokoghene Avbunudiagba; Christian Arerusuoghene Alalor; Queen Dorcas Okolocha
Journal:  Turk J Pharm Sci       Date:  2020-12-23

2.  Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets.

Authors:  Sileshi Belew; Sultan Suleman; Markos Duguma; Henok Teshome; Evelien Wynendaele; Luc Duchateau; Bart De Spiegeleer
Journal:  Malar J       Date:  2020-04-07       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.